The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

The cellular factors of innate immunity in nonpsychotic patients at high risk for schizophrenia

Journal: . 2016;116(10): 60‑65

Read: 586 times


To cite this article:

The cellular factors of innate immunity in nonpsychotic patients at high risk for schizophrenia. . 2016;116(10):60‑65. (In Russ.)
https://doi.org/10.17116/jnevro201611610160-65

Recommended articles:

References:

  1. Koljaskina GI. Immunologija v psihiatrii. Psihiatrija. Rukovodstvo dlja vrachej. T. 1. M.: Medicina; 2012. (In Russ.).
  2. Kljushnik TP, Brusov OS, Burbaeva GSh, Koljaskina GI. Sovremennyj vzgljad na osnovnye patogeneticheskie gipotezy shizofrenii. Psihiatrija. 2010;01(43);7-13. (In Russ.).
  3. Rotherrmundt M, Arolt V, Weilzsch C et al. Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology. 1998;37:4:186-193. doi: 10.1159/000026501 
  4. Kushner CG, Koljaskina GI, Kaleda VG, Cucul'kovskaja MJa. Fagocitarnaja aktivnost' nejtrofilov bol'nyh shizofreniej i shizoaffektivnym psihozom. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2000;100:4:64-65. (In Russ.).
  5. Brusov OS, Kolyaskina GI, Kaleda VG, Sekirina TP, Kushner SG, Vasilieva EF. Use of canonical correlation analysis to evaluate the strength of relationships between clinical and biological parameters. Neuroscience and Behavioral Physiology. 2011;41:4:375-383. doi: 10.1007/s11055-011-9425-6 
  6. Kolyaskina GI, Brusov OS, Sekirina TP, Androsova LV, Kushner SG, Vasilieva EF, Lavrov VF, Ebralidtze LK, Burbaeva OA, Tzuzulkovskaya MYa, Kaleda VG, Barkhatova AN. Immune system in patients with juvenile schizophrenia at the time of the first manifestation of the disease. Siberian Bulletin of psychiatry and narcology. 2008;48:1:22-26.
  7. Koljaskina GI, Brusov OS, Sekirina TP, Androsova LV, Kushner SG, Vasil'eva EF, Lavrov VF, Jebralidze LK, Burbaeva OA, Cucul'kovskaja MJa, Kaleda VG, Barhatova AN. Immunnaja sistema pri junosheskoj shizofrenii v moment pervoj manifestacii zabolevanija. Sibirskij vestnik psihiatrii i narkologii. 2008;48:1:22-26. (In Russ.).
  8. Koljaskina GI, Sekirina TP, Vasil'eva EF, Kushner SG, Petrakova LN, Barhatova AN, Omel'chenko MA. Osobennosti immunnoj sistemy i risk razvitii jendogennogo psihoza v junosheskom vozraste. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114:3:46-49. (In Russ.).
  9. Sasaki T, Nanko S, Fukuda R, Kawate T, Kunugi H, Kazamatsuri H. Change of immunological functions after acute exacerbation in schizophrenia. Biol Psychiatry. 1994;35:173-117. doi: 10.1016/0006-3223(94)91149-5 
  10. Omel'chenko MA, Golubev SA, Nikiforova IJu, Kaleda VG. Ocenka riska manifestacii jendogennyh psihozov u bol'nyh s nepsihoticheskimi psihicheskimi rasstrojstvami junosheskogo vozrasta. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114:6:14-20.(In Russ.).
  11. Carpenter W. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull. 2009;35:841-843. doi: 10.1093/schbul/sbp071
  12. Woods S, Addington J, Cadenhead K, Cannon T, Cornblatt B, Heinssen B et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American prodrome longitudinal study. Schizophr Bull. 2009;35:894-908. doi: 10.1093/schbul/sbp027 
  13. Woods S, Carlson J, McGlashan T. DSM-5 and the ‘Psychosis Risk Syndrome’: The DSM-5 proposal is better than DSM-IV. Psychosis. 2010;2:187-190. doi: 10.1080/17522439.2010.511719
  14. McGlashan T, Miller T, Woods S, Hoffman R, Davidson L. A scale for the assessment of prodromal symptoms and states. In: T. Miller, S. Mednick, T. McGlashan, J. Liberger, J. Johannessen. The Netherlands: Kluwer Academic Publishers; 2001;135-149.
  15. Miller T, McGlashan T, Woods S, Stein K, Driesen N, Corcoran C, Hoffman R, Davidson L. Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly. 1999;70:273-287.
  16. Vasil'eva EF, Brusov OS, Kaleda VG, Barhatova AN, Petrakova LN, Shilov JuE, Koljaskina GI. Citotoksicheskaja aktivnost' limfocitov natural'nyh killerov u bol'nyh s pervym pristupom jendogennogo psihoza (sravnenie dvuh sposobov testirovanija). Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013;113:6:45-49. (In Russ.).
  17. Elavazhagan S, Fatehchand K, Santhanam V, Fang H, Ren L, Gautam S, Reader B, Mo X, Cheney C, Briercheck E, Vasilakos JP, Dietsch GN, Hershberg RM, Caligiuri M, Byrd JC, Butchar JP, Tridandapani S, Granzyme B. Expression is Enhanced in Human Monocytes by TLR8 Agonists and Contributes to ADCC. J Immunol. 2015;194:6:2786-2795. doi: 10.4049/jimmunol.1402316
  18. Aranha FC, Ribeiro U Jr, Basse P, Corbett CE, Laurenti MD. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Scand J immunol. 2005;62:334-341. doi: 10.1111/j.1365-3083.2005.01681.x
  19. Atochina O, Harn D. LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol. 2000;12:1041-1049. doi: 10.1128/CDLI.12.9.1041-1049.2005
  20. Frejdlin IS. Immunnaja sistema i ee defekty. SPb.: NTFF «Polisan»; 1998. (In Russ.).
  21. Zhu M, Lei L, Zhu Z, Li Q, Guo D, Xu J, Chen J, Sha H, Zhang X, Yang X, Song B, Li B, Yan Y, Xiong Y. Excess TNF-α in the blood activates monocytes with the potential to directly form cholesteryl ester-laden cells. Acta Biochim Biophys Sin (Shanghai). 2015. doi: 10.1093/abbs/gmv092
  22. Vasil'eva EF, Sekirina TP, Androsova LV, Koljaskina GI. Vlijanie monocitov na citotoksicheskuju aktivnost' limfocitov natural'nyh killerov u bol'nyh shizofreniej. Patogenez. 2006;4:1:340-341. (In Russ.).
  23. Michel T, Hentges F, Zimmer J. Consequences of the crosstalk between monocytes/macrophages and natural killer cells. Front Immunol. 2012;3:403. doi: 10.3389/fimmu.2012.00403
  24. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004;23:255-259. doi: 10.1038/sj.emboj.7600019
  25. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol. 2012;92(5):959-975. doi: 10.1189/jlb.0212100
  26. Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry. 2010;68(10):930-941. doi: 10.1016/j.biopsych.2010.06.012
  27. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol. 2010;10:453-460. doi: 10.1038/nri2784
  28. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826-837. doi: 10.1038/nri2873

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.